Hou et al. [28] have conducted a study on obese mice, which showed that exogenous irisin treatment could reduce the body mass and visceral fat levels and improve glucose and lipid metabolic disorder. This evidence concerns the gene FNDC5 and Disorder of lipid metabolism.